These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15129392)

  • 1. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.
    Brashear A; McAfee AL; Kuhn ER; Fyffe J
    Arch Phys Med Rehabil; 2004 May; 85(5):705-9. PubMed ID: 15129392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with botulinum toxin type B for upper-limb spasticity.
    Brashear A; McAfee AL; Kuhn ER; Ambrosius WT
    Arch Phys Med Rehabil; 2003 Jan; 84(1):103-7. PubMed ID: 12589629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
    Childers MK; Brashear A; Jozefczyk P; Reding M; Alexander D; Good D; Walcott JM; Jenkins SW; Turkel C; Molloy PT
    Arch Phys Med Rehabil; 2004 Jul; 85(7):1063-9. PubMed ID: 15241751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
    Simpson DM; Alexander DN; O'Brien CF; Tagliati M; Aswad AS; Leon JM; Gibson J; Mordaunt JM; Monaghan EP
    Neurology; 1996 May; 46(5):1306-10. PubMed ID: 8628472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
    Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
    Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
    PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.
    Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
    Adv Ther; 2019 Jan; 36(1):187-199. PubMed ID: 30484117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
    Simpson DM; Gracies JM; Yablon SA; Barbano R; Brashear A;
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):380-5. PubMed ID: 18977811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.
    Abo M; Shigematsu T; Hara H; Matsuda Y; Nimura A; Yamashita Y; Takahashi K
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized Trial.
    Wein T; Esquenazi A; Jost WH; Ward AB; Pan G; Dimitrova R
    PM R; 2018 Jul; 10(7):693-703. PubMed ID: 29330071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ; Kwon BS; Park YG
    Arch Phys Med Rehabil; 2020 Sep; 101(9):1485-1496. PubMed ID: 32497599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
    Olvey EL; Armstrong EP; Grizzle AJ
    Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.
    Gracies JM; Bayle N; Goldberg S; Simpson DM
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1303-11. PubMed ID: 24709034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE).
    Masakado Y; Abo M; Kondo K; Saeki S; Saitoh E; Dekundy A; Hanschmann A; Kaji R;
    J Neurol; 2020 Jul; 267(7):2029-2041. PubMed ID: 32219557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.